Primary prevention of haemophilus influenzae type b.
Routine immunisation of infants against Haemophilus influenzae type b (Hib) has the potential to prevent up to 1200 cases of serious infection and 60 deaths every year in the United Kingdom. Sara Hodgson reports the findings of a study in the Oxford region to determine the safety and immunogenicity of the Hib conjugate vaccine PRP-T when given to British infants in concurrence with primary immunisations, according to the accelerated schedule of two, three and four months of age.
Hodgson
S
S
D001428:Bacterial Vaccines / Q000009:adverse effects / Q000627:therapeutic use*; D004739:England / Q000453:epidemiology; D006192:Haemophilus Infections / Q000453:epidemiology / Q000517:prevention & control*; D006193:Haemophilus influenzae; D006801:Humans; D007223:Infant
D001428:Bacterial Vaccines